Gene · 3290
Papers3,100
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,100
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic Analysis of Livers of Inactive Carriers of Hepatitis B Virus With Distinct Expression of Hepatitis B Surface Antigen. | J Infect Dis | 2022 | 34279652 | PubTator, text mining | PubMed |
| Aging versus youth: Endocrine aspects of vulnerability for COVID-19. | Rev Endocr Metab Disord | 2022 | 33860905 | PubTator, text mining | PubMed |
| On-tissue chemical derivatization in mass spectrometry imaging. | Mass Spectrom Rev | 2022 | 33433028 | PubTator, text mining | PubMed |
| Life Course Impact of Glucocorticoids During Pregnancy on Muscle Development and Function. | Front Anim Sci | 2021 | 36325303 | PubTator, text mining | PubMed |
| The Menstrual Endometrium: From Physiology to Future Treatments. | Front Reprod Health | 2021 | 36304053 | PubTator, text mining | PubMed |
| Exploring the therapeutic mechanisms of Cassia glauca in diabetes mellitus through network pharmacology, molecular docking and molecular dynamics. | RSC Adv | 2021 | 35492478 | PubTator, text mining | PubMed |
| Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro. | Front Pharmacol | 2021 | 35401158 | PubTator, text mining | PubMed |
| Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales. | Front Pharmacol | 2021 | 35126141 | PubTator, text mining | PubMed |
| Secondary diabetes as a rare complication of glycogen storage disease 1a: case report and review of literature. | Pediatr Endocrinol Diabetes Metab | 2021 | 35114770 | PubTator, text mining | PubMed |
| Enhanced Angiogenesis by 11βHSD1 Blockage Is Insufficient to Improve Reperfusion Following Hindlimb Ischaemia. | Front Cardiovasc Med | 2021 | 35097015 | PubTator, text mining | PubMed |
| Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis. | Front Immunol | 2021 | 35095918 | PubTator, text mining | PubMed |
| Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment. | Front Pharmacol | 2021 | 35095530 | PubTator, text mining | PubMed |
| Expression Profiles of GILZ and SGK-1 in Potentially Malignant and Malignant Human Oral Lesions. | Front Oral Health | 2021 | 35048019 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Prognostic Microenvironment-Related Genes in Invasive Breast Cancer. | Front Oncol | 2021 | 35047378 | PubTator, text mining | PubMed |
| Recent Progress in Cardiovascular Research Involving Single-Cell Omics Approaches. | Front Cardiovasc Med | 2021 | 34977189 | PubTator, text mining | PubMed |
| Development and Validation of a Novel Hypoxia-Related Long Noncoding RNA Model With Regard to Prognosis and Immune Features in Breast Cancer. | Front Cell Dev Biol | 2021 | 34977036 | PubTator, text mining | PubMed |
| Altered Cortisol Metabolism Increases Nocturnal Cortisol Bioavailability in Prepubertal Children With Type 1 Diabetes Mellitus. | Front Endocrinol (Lausanne) | 2021 | 34970219 | PubTator, text mining | PubMed |
| Prognostic Model Construction and Immune Microenvironment Analysis of Breast Cancer Based on Ferroptosis-Related lncRNAs. | Int J Gen Med | 2021 | 34949938 | PubTator, text mining | PubMed |
| Altered Steroidome in Women with Gestational Diabetes Mellitus: Focus on Neuroactive and Immunomodulatory Steroids from the 24th Week of Pregnancy to Labor. | Biomolecules | 2021 | 34944390 | PubTator, text mining | PubMed |
| Homeostatic Regulation of Glucocorticoid Receptor Activity by Hypoxia-Inducible Factor 1: From Physiology to Clinic. | Cells | 2021 | 34943949 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3290/papers?page=33